Webinar Date/Time: Tuesday, August 13th, 2024 at 11am EDT|8am PDT|4pm BST|5pm CEST
When sponsors invest in best-of-breed solutions that leverage intelligent integration and workflow automation, it is possible to support a positive technology experience for sites and optimize the clinical supply chain. In this webinar, IQVIA patient technology experts will dive into the flexibility you have when deciding what approach to take when implementing patient technology into your next trial.
Register Free: https://www.appliedclinicaltrialsonline.com/act/patient-technology
Event overview
To improve data quality, reduce site effort, optimize workflows in your clinical trials, and address problems at hand, you need the right technology at the right time. While an integrated platform approach might be best to tackle your goals, you may, instead, only need one or two point products.
When sponsors invest in best-of-breed solutions that leverage intelligent integration and workflow automation, it is possible to support a positive technology experience for sites and optimize the clinical supply chain.
In this webinar, IQVIA patient technology experts will dive into the flexibility you have when deciding what approach to take when implementing patient technology into your next trial.
Three key take-aways
Who Should Attend
Speakers:
Anthony Mikulaschek
Vice President, Commercialization, IQVIA Patient Suite
IQVIA
As the vice president of commercialization for the Patient Suite at IQVIA, Anthony Mikulaschek is responsible for the commercialization of IQVIA's eCOA, eConsent, and IRT platforms. This includes pricing and sales strategies, opportunity configuration, market needs review, IQVIA technology market placement, and strategy. Anthony has extensive experience in validated system configuration, implementation, systems integration, business process reengineering, IT operations, and consulting. He has successfully led the development, delivery, and management of technology solutions for over 37 years. This includes 29 years of experience in the pharmaceutical sector.
Kevin Landells
Vice President, Delivery, IQVIA Patient Suite
IQVIA
Kevin has over 25 years of experience in the IRT/ RTSM industry, having worked across many technical and project management leadership roles. Experienced with developing and leading global teams that deliver managed services spanning operations, project management, client partnerships, and business transformation, Kevin is passionate about improving healthcare and utilizing technology that makes a real difference to patients’ lives. Kevin holds a bachelor’s degree in computer science from Hertfordshire University.
Register Free: https://www.appliedclinicaltrialsonline.com/act/patient-technology
What Can ClinOps Learn from Pre-Clinical?
August 10th 2021Dr. Hanne Bak, Senior Vice President of Preclinical Manufacturing and Process Development at Regeneron speaks about her role at the company as well as their work with monoclonal antibodies, the regulatory side of manufacturing, and more.